BioSpace News Archive

CEO Connection member CEO, Rick Salerno of AES Controls announces a solution to the ventilator shortage that will help save lives:

PatientWing (www.patientwing.com), a company with the mission of connecting patients with clinical trials, today announced that it has launched covid19studies.org to increase enrollment in COVID-19 clinical trials.

Vericel Corporation today announced that as a result of the COVID-19 pandemic, to support the health and well-being of our employees and shareholders, and to comply with state stay-at-home orders, including the Commonwealth of Massachusetts’ Executive Order prohibiting gatherings of more than ten people, its Board of Directors has approved a c

The guide was developed by Ariadne Labs and The Conversation Project with generous support from the Cambia Health Foundation

Los Angeles-based materials science company American Elements announced that the company and its catalog sales operations remain open during the evolving COVID-19 pandemic

TrialAssure® – the technology arm of MMS and leading, global software company focused on advancing clinical trial transparency – has won the “Data Solution of the Year—Healthcare” award in the 2020 Data Breakthrough Awards

Easy Breathe, the most popular online CPAP store, serves as a trusted source of information and CPAP supplies for millions of people with obstructive sleep apnea.

Lawsuit is part of 3M’s national and global efforts to fight price gouging and counterfeiting of N95 respirators used on the frontlines of the fight against COVID-19

The U.S. Food and Drug Administration issued the second emergency use authorization (EUA) to decontaminate compatible N95 or N95-equivalent respirators for reuse by health care workers in hospital settings.

Darmiyan, Inc. is pleased to announce the initial closing of a $6M Series Seed investment round led by the pharmaceutical giant Eisai, creating a major business collaboration opportunity between the two companies, one focused on advanced brain diagnostics, and the other focused on Alzheimer’s therapeutics.